Evercore ISI Group Maintains Outperform on Minimed Group, Raises Price Target to $27
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $20 to $27.
Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $20 to $27.